Pediatric Cancer, Volume 2
Kurzinformation
inkl. MwSt. Versandinformationen
Artikel zZt. nicht lieferbar
Artikel zZt. nicht lieferbar

Beschreibung
A general introduction to the principles of diagnosis and treatment of children with brain tumors is presented. Molecular characterization of solid tumors is also presented. Molecular pathways provide putative targets for new therapies. High resolution magic spinning NMR spectroscopy is explained, which is used to determine metabolic profiles for small pieces of intact tissue and whole cells in culture. The differences between adult and pediatric brain tumors are outlined. It is emphasized that pediatric low-grade gliomas need lower doses of antidrugs such as cisplatin/etoposide. It is explained that tumor suppressor genes and oncogenes play a crucial role in the development and progression of human malignancies, including those in children. Neurofibromatosis type-1 is a common genetic disorder with a high prevalence in CNS abnormalities including tumors in children; which is discussed in detail. Various neuroradiological imaging modalities in children with leukemia are detailed. Also are detailed results of clinical trials in pediatric brain tumors, such as medulloblastoma, ependymoma, craniopharyngioma, low-grade glioma, high-grade glioma, brainstem glioma, and germ cell tumors, using radiotherapy. Considering the clinical importance of epilepsy in the primary brain tumors in children, its symptoms, diagnosis, and treatments (surgery and antiepileptic drugs) are discussed. von Hayat, M. A.
Produktdetails
So garantieren wir Dir zu jeder Zeit Premiumqualität.
Über den Autor
- paperback
- 304 Seiten
- Erschienen 2010
- Springer US
- Gebunden
- 576 Seiten
- Erschienen 2017
- Springer
- paperback
- 160 Seiten
- Erschienen 2012
- American College of Physicians
- hardcover
- 352 Seiten
- Erschienen 2010
- Urban & Fischer Verlag/Else...
- hardcover
- 1378 Seiten
- Erschienen 2014
- McGraw-Hill Medical
- hardcover
- 550 Seiten
- Erschienen 1992
- Mosby
- Gebunden
- 850 Seiten
- Erschienen 2019
- Elsevier
- Gebunden
- 456 Seiten
- Erschienen 2005
- Thieme
- Gebunden
- 2448 Seiten
- Erschienen 2018
- Lippincott Williams&Wilki
- hardcover -
- Erschienen 2004
- Novartis Pharma
- Gebunden
- 768 Seiten
- Erschienen 2021
- Elsevier
- Blätter
- 416 Seiten
- Erschienen 2022
- Lippincott Williams&Wilki
- Gebunden
- 464 Seiten
- Erschienen 2021
- Thieme
- hardcover
- 1916 Seiten
- Erschienen 2009
- Springer
- Kartoniert
- 838 Seiten
- Erschienen 2020
- Wissenschaftliche Verlagsge...
- Gebunden
- 451 Seiten
- Erschienen 2004
- Humana
- hardcover
- 800 Seiten
- Erschienen 2001
- American Cancer Society




